ArticleThe American journal of pathology2014

miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.

Ximena V Qadir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.